Biography

Dr. Smalling is a native Texan who received his B.S. in Aerospace Engineering and M.S.M.E. in Bio-Medical Engineering from UT Austin, and PhD from what is now The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences.  He is an AOA graduate of McGovern Medical School at UTHealth and did his residency training and cardiology fellowship at the University of California-San Diego. Board certified in internal medicine, cardiovascular medicine, and interventional cardiology, he is Past President of the American Heart Association, Texas Affiliate, and Past President of the Medical Staff of Memorial Hermann-Texas Medical Center where he was also named a Distinguished Physician.  He has been honored as a Distinguished Alumnus of both McGovern Medical School (1991) and the Cockrell College of Engineering at the University Texas at Austin (1997).

Named an America’s Top Doctor for the past fifteen years, Dr. Smalling received the Distinguished Service Award from the American Heart Association Texas Affiliate in 1990.  He is on the editorial boards of Catheterization and Cardiovascular Interventions, The Journal of Interventional Cardiology, and Journal of the American College of Cardiology- Interventions and is a past associate editor for Circulation. In 2016, he was named a Master in the Society of Catheterization and Cardiovascular Interventions. In addition, he holds six patents and Co-founded Windmill Cardiovascular Systems, to produce a new implantable left ventricular assist device.  He and his team has developed the first valveless, pulsatile flow LVAD that pumps in synchrony with the cardiac cycle and automatically changes its pumping function to optimize cardiac function.

Dr. Smalling specializes in the treatment of valvular heart disease and adult congenital heart disease percutaneously.  His research interests include development of 3-D, fluoroscopically guided structural heart interventions and reduction of reperfusion injury by mechanical LV unloading and endothelin inhibition. Clinically, his team is actively pursuing the role of very early treatment of patients with acute myocardial infarction and evaluating new percutaneous methodologies for treating valvular heart disease.

Dr. Smalling is the author of over 250 peer-reviewed articles, 25 book chapters, 2 books, and more than 15 web-based CME articles.  He and his wife Sharon have 3 children, Geoffrey, Elizabeth and Stephanie and 2 grandchildren.  They enjoy cooking, cycling, skiing and traveling together.

CV Richard Smalling, MD PhD

Richard Smalling MD PhD Physician Biography BRIEF

In the news: Advanced technology and new opportunities provided in Toshiba collaborative agreement improves cardiac care.

Accomplishments:

  • James D. Woods Distinguished Chair in Cardiovascular Medicine
  • America’s Top Doctors and Texas Super Doctor
  • UTHealth McGovern Medical School: Distinguished Alumnus Award
  • The University of Texas at Austin, College of Engineering: Distinguished Alumnus Award
  • Distinguished Physician Award Memorial Hermann Hospital

Education

Medical Degree
The University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School
Doctoral Degree
The University of Texas Health Science Center at Houston (UTHealth)
Residency
University of California, San Diego Medical Center
Fellowship
University of California, San Diego Medical Center

Areas of Interests

Clinical Interests

  • Structural Heart Disease including Percutaneous Aortic Valve Replacement (TAVR), Percutaneous Mitral Valve Repair (E-Valve), Mitral Valvuloplasty, Percutaneous ASD Repair, Septal Coiling for HOCM.
  • Peripheral Vascular Interventions Including Limb Salvage, Percutaneous EVAR under local anesthesia, and Carotid Stenting
  • Advanced Coronary Interventions including CTO and High Risk, Supported PCI with Percutaneous LV Assist

Research Interests

His research interests include advanced intravascular imaging procedures for coronary artery disease and mechanical and pharmacologic reduction of ischemic myocardial injury. Clinically, his team is actively pursuing the role of very early treatment of patients with acute myocardial infarction and evaluating new percutaneous methodologies for treating valvular heart disease.

Board Certifications

  • American Board of Internal Medicine
  • American Board of Internal Medicine – Cardiovascular Disease
  • American Board of Internal Medicine – Cardiology